AML (Leukemia) diagnosis after Car T therapy
I received Car T therapy for Non Hodgkins Lymphoma in 2018. The therapy was very successful with the complete eradication of the disease. Recently I have been diagnosed with AML (Luekemia). I was advised the likely reason of this unfortunate diagnosis, is the bone marrow has been damaged by the high doses of Chemo Drugs I was administered, prior to becoming eligible to receive the Car T treatment.
I would appreciate hearing from anyone who may had a similar.
experience.
If you are familiar with this, how was the AML treated?
I appreciate any insight you may be able to share.
Interested in more discussions like this? Go to the Bone Marrow Transplant (BMT) & CAR-T Cell Therapy Support Group.
Good morning, Bob. Sounds like you’re rebounding nicely from the AML treatments and hit the all-encouraging remission point! That’s fantastic news! I’m sure you did a lot of soul searching about whether to go ahead with the transplant or not. Since you’ve already been through CAR-T therapy, you’re plenty familiar with that road to recovery, so I can certainly respect your decision. I’m so happy you’re doing well and feeling so much better. Are you on a maintenance drug?
Good morning Lori, I am still undergoing maintenance treatment. Where I started with a twenty eight day cycle with treatments every day for two weeks with a two week recovery period, I am currently on a forty two day cycle, seven days of treatment with a 36 day recovery period.